Literature DB >> 17242207

Molecular dissection of formation of senescence-associated heterochromatin foci.

Rugang Zhang1, Wei Chen, Peter D Adams.   

Abstract

Senescence is characterized by an irreversible cell proliferation arrest. Specialized domains of facultative heterochromatin, called senescence-associated heterochromatin foci (SAHF), are thought to contribute to the irreversible cell cycle exit in many senescent cells by repressing the expression of proliferation-promoting genes such as cyclin A. SAHF contain known heterochromatin-forming proteins, such as heterochromatin protein 1 (HP1) and the histone H2A variant macroH2A, and other specialized chromatin proteins, such as HMGA proteins. Previously, we showed that a complex of histone chaperones, histone repressor A (HIRA) and antisilencing function 1a (ASF1a), plays a key role in the formation of SAHF. Here we have further dissected the series of events that contribute to SAHF formation. We show that each chromosome condenses into a single SAHF focus. Chromosome condensation depends on the ability of ASF1a to physically interact with its deposition substrate, histone H3, in addition to its cochaperone, HIRA. In cells entering senescence, HP1gamma, but not the related proteins HP1alpha and HP1beta, becomes phosphorylated on serine 93. This phosphorylation is required for efficient incorporation of HP1gamma into SAHF. Remarkably, however, a dramatic reduction in the amount of chromatin-bound HP1 proteins does not detectably affect chromosome condensation into SAHF. Moreover, abundant HP1 proteins are not required for the accumulation in SAHF of histone H3 methylated on lysine 9, the recruitment of macroH2A proteins, nor other hallmarks of senescence, such as the expression of senescence-associated beta-galactosidase activity and senescence-associated cell cycle exit. Based on our results, we propose a stepwise model for the formation of SAHF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242207      PMCID: PMC1820509          DOI: 10.1128/MCB.02019-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  86 in total

1.  Transcriptional activation triggers deposition and removal of the histone variant H3.3.

Authors:  Brian E Schwartz; Kami Ahmad
Journal:  Genes Dev       Date:  2005-03-17       Impact factor: 11.361

2.  Structural basis for the interaction of Asf1 with histone H3 and its functional implications.

Authors:  Florence Mousson; Aurélie Lautrette; Jean-Yves Thuret; Morgane Agez; Régis Courbeyrette; Béatrice Amigues; Emmanuelle Becker; Jean-Michel Neumann; Raphaël Guerois; Carl Mann; Françoise Ochsenbein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

3.  Genome-scale profiling of histone H3.3 replacement patterns.

Authors:  Yoshiko Mito; Jorja G Henikoff; Steven Henikoff
Journal:  Nat Genet       Date:  2005-09-11       Impact factor: 38.330

4.  Domain-wide displacement of histones by activated heat shock factor occurs independently of Swi/Snf and is not correlated with RNA polymerase II density.

Authors:  Jing Zhao; Jorge Herrera-Diaz; David S Gross
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  Variant histone H3.3 is deposited at sites of nucleosomal displacement throughout transcribed genes while active histone modifications show a promoter-proximal bias.

Authors:  Christiane Wirbelauer; Oliver Bell; Dirk Schübeler
Journal:  Genes Dev       Date:  2005-08-01       Impact factor: 11.361

Review 6.  Epigenetics, histone H3 variants, and the inheritance of chromatin states.

Authors:  S Henikoff; E McKittrick; K Ahmad
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2004

7.  BRAFE600-associated senescence-like cell cycle arrest of human naevi.

Authors:  Chrysiis Michaloglou; Liesbeth C W Vredeveld; Maria S Soengas; Christophe Denoyelle; Thomas Kuilman; Chantal M A M van der Horst; Donné M Majoor; Jerry W Shay; Wolter J Mooi; Daniel S Peeper
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

8.  Tumour biology: senescence in premalignant tumours.

Authors:  Manuel Collado; Jesús Gil; Alejo Efeyan; Carmen Guerra; Alberto J Schuhmacher; Marta Barradas; Alberto Benguría; Angel Zaballos; Juana M Flores; Mariano Barbacid; David Beach; Manuel Serrano
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

9.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Authors:  Zhenbang Chen; Lloyd C Trotman; David Shaffer; Hui-Kuan Lin; Zohar A Dotan; Masaru Niki; Jason A Koutcher; Howard I Scher; Thomas Ludwig; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

10.  Oncogene-induced senescence as an initial barrier in lymphoma development.

Authors:  Melanie Braig; Soyoung Lee; Christoph Loddenkemper; Cornelia Rudolph; Antoine H F M Peters; Brigitte Schlegelberger; Harald Stein; Bernd Dörken; Thomas Jenuwein; Clemens A Schmitt
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

View more
  188 in total

1.  ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.

Authors:  Hua Li; Benjamin G Bitler; Vinod Vathipadiekal; Marie E Maradeo; Michael Slifker; Caretha L Creasy; Peter J Tummino; Paul Cairns; Michael J Birrer; Rugang Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-05

2.  Global heterochromatin loss: a unifying theory of aging?

Authors:  Amy Tsurumi; Willis X Li
Journal:  Epigenetics       Date:  2012-07-01       Impact factor: 4.528

Review 3.  Nuclear reprogramming and epigenetic rejuvenation.

Authors:  Prim B Singh; Fred Zacouto
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

Review 4.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

Review 5.  Assessing cell and organ senescence biomarkers.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

Review 6.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

7.  A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

Authors:  Katrin Tschöp; Andrew R Conery; Larisa Litovchick; James A Decaprio; Jeffrey Settleman; Ed Harlow; Nicholas Dyson
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

8.  ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.

Authors:  Linan Ha; Takeshi Ichikawa; Miriam Anver; Ross Dickins; Scott Lowe; Norman E Sharpless; Paul Krimpenfort; Ronald A Depinho; Dorothy C Bennett; Elena V Sviderskaya; Glenn Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 9.  The Chromatin Landscape of Cellular Senescence.

Authors:  Steven W Criscione; Yee Voan Teo; Nicola Neretti
Journal:  Trends Genet       Date:  2016-09-28       Impact factor: 11.639

10.  Significance of cellular senescence in aging and cancer.

Authors:  Angela Grimes; Sathees B C Chandra
Journal:  Cancer Res Treat       Date:  2009-12-31       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.